Is a law enough to provide a better prognosis for Brazilian melanoma patients or education is still a gap?
According to Brazilian Law 12.732/12 (“60‐day law”), cancer patients have 60 days after diagnosis for beginning treatment at the Unified Health System (SUS). The study aimed to evaluate the achievement and effectiveness of the ‘60‐day law’ for melanoma patients in a SUS cancer reference unit. A retr...
Gespeichert in:
| Veröffentlicht in: | The International journal of health planning and management 2022-07, Vol.37 (4), p.2479-2484 |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 2484 |
|---|---|
| container_issue | 4 |
| container_start_page | 2479 |
| container_title | The International journal of health planning and management |
| container_volume | 37 |
| creator | Marcelino, Bruno Aquino Soares, Fernanda Hermeto Curi, Marcela Lima de Castro Alves Wainstein, Alberto Julius Drummond‐Lage, Ana Paula |
| description | According to Brazilian Law 12.732/12 (“60‐day law”), cancer patients have 60 days after diagnosis for beginning treatment at the Unified Health System (SUS). The study aimed to evaluate the achievement and effectiveness of the ‘60‐day law’ for melanoma patients in a SUS cancer reference unit. A retrospective study analysed 58 medical charts from patients with the initial diagnosis performed before and after the “60‐day law”. The Law does not change the time interval between diagnosis and the beginning of treatment, and after the Law, patients presented a worse overall survival (p |
| doi_str_mv | 10.1002/hpm.3491 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2658233517</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2658233517</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2791-79c6f651edadb87a1c43e669aaea9f2f1b2f284cd9c5df107d72a6b8867702443</originalsourceid><addsrcrecordid>eNp1kNFKwzAUhoMobk7BJ5CAN950JmnaNFeiQ50w0Qu9Lml7umW0TU1ax3x6MzcVBK8O55yPj58foVNKxpQQdrlo63HIJd1DQ0qkDKiI6D4aEsFlEIsoHKAj55aE-B-Vh2gQRjzhgvAhWj44rHClVhga088XuDO4teZdF-DvGXQd2M1h3hinHS6NxTdWfehKqwbXUKnG1Aq3qtPQdA77NxR97lfTYM-7TleVF81Ve3WMDkpVOTjZzRF6vbt9mUyD2dP9w-R6FuRMSBoImcdlHFEoVJElQtGchxDHUilQsmQlzVjJEp4XMo-KkhJRCKbiLEliIQjjPByhi63Xx37rwXVprV0Olc8Kpncpi6OEhWFEhUfP_6BL09vGp_OUJJKE3vorzK1xzkKZtlbXyq5TStJN_6nvP93079GznbDPaih-wO_CPRBsgZWuYP2vKJ0-P34JPwHNI45m</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2690903867</pqid></control><display><type>article</type><title>Is a law enough to provide a better prognosis for Brazilian melanoma patients or education is still a gap?</title><source>Access via Wiley Online Library</source><source>Applied Social Sciences Index & Abstracts (ASSIA)</source><creator>Marcelino, Bruno Aquino ; Soares, Fernanda Hermeto ; Curi, Marcela Lima de Castro ; Alves Wainstein, Alberto Julius ; Drummond‐Lage, Ana Paula</creator><creatorcontrib>Marcelino, Bruno Aquino ; Soares, Fernanda Hermeto ; Curi, Marcela Lima de Castro ; Alves Wainstein, Alberto Julius ; Drummond‐Lage, Ana Paula</creatorcontrib><description>According to Brazilian Law 12.732/12 (“60‐day law”), cancer patients have 60 days after diagnosis for beginning treatment at the Unified Health System (SUS). The study aimed to evaluate the achievement and effectiveness of the ‘60‐day law’ for melanoma patients in a SUS cancer reference unit. A retrospective study analysed 58 medical charts from patients with the initial diagnosis performed before and after the “60‐day law”. The Law does not change the time interval between diagnosis and the beginning of treatment, and after the Law, patients presented a worse overall survival (p < 0.001). In conclusion, the ‘60‐day law’ was not effective.
Highlights
Brazilian law requires that cancer treatment begins within 60 days of diagnosis.
This time is an indicator of access to health services.
The law is insufficient for a better outcome for melanoma patients.
Melanoma awareness tools must be used for patients and general practitioners.</description><identifier>ISSN: 0749-6753</identifier><identifier>EISSN: 1099-1751</identifier><identifier>DOI: 10.1002/hpm.3491</identifier><identifier>PMID: 35484704</identifier><language>eng</language><publisher>England: Wiley Subscription Services, Inc</publisher><subject>Cancer ; Diagnosis ; education ; legislation ; Medical diagnosis ; Medical prognosis ; Melanoma ; outcomes ; Patients ; Skin melanoma</subject><ispartof>The International journal of health planning and management, 2022-07, Vol.37 (4), p.2479-2484</ispartof><rights>2022 John Wiley & Sons Ltd.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c2791-79c6f651edadb87a1c43e669aaea9f2f1b2f284cd9c5df107d72a6b8867702443</citedby><cites>FETCH-LOGICAL-c2791-79c6f651edadb87a1c43e669aaea9f2f1b2f284cd9c5df107d72a6b8867702443</cites><orcidid>0000-0003-0289-8953</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fhpm.3491$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fhpm.3491$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,27924,27925,30999,45574,45575</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35484704$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Marcelino, Bruno Aquino</creatorcontrib><creatorcontrib>Soares, Fernanda Hermeto</creatorcontrib><creatorcontrib>Curi, Marcela Lima de Castro</creatorcontrib><creatorcontrib>Alves Wainstein, Alberto Julius</creatorcontrib><creatorcontrib>Drummond‐Lage, Ana Paula</creatorcontrib><title>Is a law enough to provide a better prognosis for Brazilian melanoma patients or education is still a gap?</title><title>The International journal of health planning and management</title><addtitle>Int J Health Plann Manage</addtitle><description>According to Brazilian Law 12.732/12 (“60‐day law”), cancer patients have 60 days after diagnosis for beginning treatment at the Unified Health System (SUS). The study aimed to evaluate the achievement and effectiveness of the ‘60‐day law’ for melanoma patients in a SUS cancer reference unit. A retrospective study analysed 58 medical charts from patients with the initial diagnosis performed before and after the “60‐day law”. The Law does not change the time interval between diagnosis and the beginning of treatment, and after the Law, patients presented a worse overall survival (p < 0.001). In conclusion, the ‘60‐day law’ was not effective.
Highlights
Brazilian law requires that cancer treatment begins within 60 days of diagnosis.
This time is an indicator of access to health services.
The law is insufficient for a better outcome for melanoma patients.
Melanoma awareness tools must be used for patients and general practitioners.</description><subject>Cancer</subject><subject>Diagnosis</subject><subject>education</subject><subject>legislation</subject><subject>Medical diagnosis</subject><subject>Medical prognosis</subject><subject>Melanoma</subject><subject>outcomes</subject><subject>Patients</subject><subject>Skin melanoma</subject><issn>0749-6753</issn><issn>1099-1751</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>7QJ</sourceid><recordid>eNp1kNFKwzAUhoMobk7BJ5CAN950JmnaNFeiQ50w0Qu9Lml7umW0TU1ax3x6MzcVBK8O55yPj58foVNKxpQQdrlo63HIJd1DQ0qkDKiI6D4aEsFlEIsoHKAj55aE-B-Vh2gQRjzhgvAhWj44rHClVhga088XuDO4teZdF-DvGXQd2M1h3hinHS6NxTdWfehKqwbXUKnG1Aq3qtPQdA77NxR97lfTYM-7TleVF81Ve3WMDkpVOTjZzRF6vbt9mUyD2dP9w-R6FuRMSBoImcdlHFEoVJElQtGchxDHUilQsmQlzVjJEp4XMo-KkhJRCKbiLEliIQjjPByhi63Xx37rwXVprV0Olc8Kpncpi6OEhWFEhUfP_6BL09vGp_OUJJKE3vorzK1xzkKZtlbXyq5TStJN_6nvP93079GznbDPaih-wO_CPRBsgZWuYP2vKJ0-P34JPwHNI45m</recordid><startdate>202207</startdate><enddate>202207</enddate><creator>Marcelino, Bruno Aquino</creator><creator>Soares, Fernanda Hermeto</creator><creator>Curi, Marcela Lima de Castro</creator><creator>Alves Wainstein, Alberto Julius</creator><creator>Drummond‐Lage, Ana Paula</creator><general>Wiley Subscription Services, Inc</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QJ</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-0289-8953</orcidid></search><sort><creationdate>202207</creationdate><title>Is a law enough to provide a better prognosis for Brazilian melanoma patients or education is still a gap?</title><author>Marcelino, Bruno Aquino ; Soares, Fernanda Hermeto ; Curi, Marcela Lima de Castro ; Alves Wainstein, Alberto Julius ; Drummond‐Lage, Ana Paula</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2791-79c6f651edadb87a1c43e669aaea9f2f1b2f284cd9c5df107d72a6b8867702443</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Cancer</topic><topic>Diagnosis</topic><topic>education</topic><topic>legislation</topic><topic>Medical diagnosis</topic><topic>Medical prognosis</topic><topic>Melanoma</topic><topic>outcomes</topic><topic>Patients</topic><topic>Skin melanoma</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Marcelino, Bruno Aquino</creatorcontrib><creatorcontrib>Soares, Fernanda Hermeto</creatorcontrib><creatorcontrib>Curi, Marcela Lima de Castro</creatorcontrib><creatorcontrib>Alves Wainstein, Alberto Julius</creatorcontrib><creatorcontrib>Drummond‐Lage, Ana Paula</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>Applied Social Sciences Index & Abstracts (ASSIA)</collection><collection>MEDLINE - Academic</collection><jtitle>The International journal of health planning and management</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Marcelino, Bruno Aquino</au><au>Soares, Fernanda Hermeto</au><au>Curi, Marcela Lima de Castro</au><au>Alves Wainstein, Alberto Julius</au><au>Drummond‐Lage, Ana Paula</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Is a law enough to provide a better prognosis for Brazilian melanoma patients or education is still a gap?</atitle><jtitle>The International journal of health planning and management</jtitle><addtitle>Int J Health Plann Manage</addtitle><date>2022-07</date><risdate>2022</risdate><volume>37</volume><issue>4</issue><spage>2479</spage><epage>2484</epage><pages>2479-2484</pages><issn>0749-6753</issn><eissn>1099-1751</eissn><abstract>According to Brazilian Law 12.732/12 (“60‐day law”), cancer patients have 60 days after diagnosis for beginning treatment at the Unified Health System (SUS). The study aimed to evaluate the achievement and effectiveness of the ‘60‐day law’ for melanoma patients in a SUS cancer reference unit. A retrospective study analysed 58 medical charts from patients with the initial diagnosis performed before and after the “60‐day law”. The Law does not change the time interval between diagnosis and the beginning of treatment, and after the Law, patients presented a worse overall survival (p < 0.001). In conclusion, the ‘60‐day law’ was not effective.
Highlights
Brazilian law requires that cancer treatment begins within 60 days of diagnosis.
This time is an indicator of access to health services.
The law is insufficient for a better outcome for melanoma patients.
Melanoma awareness tools must be used for patients and general practitioners.</abstract><cop>England</cop><pub>Wiley Subscription Services, Inc</pub><pmid>35484704</pmid><doi>10.1002/hpm.3491</doi><tpages>6</tpages><orcidid>https://orcid.org/0000-0003-0289-8953</orcidid></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0749-6753 |
| ispartof | The International journal of health planning and management, 2022-07, Vol.37 (4), p.2479-2484 |
| issn | 0749-6753 1099-1751 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2658233517 |
| source | Access via Wiley Online Library; Applied Social Sciences Index & Abstracts (ASSIA) |
| subjects | Cancer Diagnosis education legislation Medical diagnosis Medical prognosis Melanoma outcomes Patients Skin melanoma |
| title | Is a law enough to provide a better prognosis for Brazilian melanoma patients or education is still a gap? |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T23%3A27%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Is%20a%20law%20enough%20to%20provide%20a%20better%20prognosis%20for%20Brazilian%20melanoma%20patients%20or%20education%20is%20still%20a%20gap?&rft.jtitle=The%20International%20journal%20of%20health%20planning%20and%20management&rft.au=Marcelino,%20Bruno%20Aquino&rft.date=2022-07&rft.volume=37&rft.issue=4&rft.spage=2479&rft.epage=2484&rft.pages=2479-2484&rft.issn=0749-6753&rft.eissn=1099-1751&rft_id=info:doi/10.1002/hpm.3491&rft_dat=%3Cproquest_cross%3E2658233517%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2690903867&rft_id=info:pmid/35484704&rfr_iscdi=true |